Current Status of Malaria and Potential for Control
AUTOR(ES)
Phillips, R. S.
FONTE
American Society for Microbiology
RESUMO
Malaria remains one of the world's worst health problems with 1.5 to 2.7 million deaths annually; these deaths are primarily among children under 5 years of age and pregnant women in sub-Saharan Africa. Of significance, more people are dying from malaria today than 30 years ago. This review considers the factors which have contributed to this gloomy picture, including those which relate to the vector, the female anopheline mosquito; to human activity such as creating new mosquito breeding sites, the impact of increased numbers of people, and how their migratory behavior can increase the incidence and spread of malaria; and the problems of drug resistance by the parasites to almost all currently available antimalarial drugs. In a selective manner, this review describes what is being done to ameliorate this situation both in terms of applying existing methods in a useful or even crucial role in control and prevention and in terms of new additions to the antimalarial armory that are being developed. Topics covered include biological control of mosquitoes, the use of insecticide-impregnated bed nets, transgenic mosquitoes manipulated for resistance to malaria parasites, old and new antimalarial drugs, drug resistance and how best to maintain the useful life of antimalarials, immunity to malaria and the search for antimalarial vaccines, and the malaria genome project and the potential benefits to accrue from it.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=88970Documentos Relacionados
- Current vector control challenges in the fight against malaria in Brazil
- Lung cancer: Current Status and Prospects for the Future
- Preparation for Medical Librarianship: Status and Potential *
- Current and potential future drug treatments for osteoporosis.
- CpG Methylation Analysis—Current Status of Clinical Assays and Potential Applications in Molecular Diagnostics : A Report of the Association for Molecular Pathology